SMIRNE, Carlo
 Distribuzione geografica
Continente #
EU - Europa 3.376
NA - Nord America 3.065
AS - Asia 2.330
SA - Sud America 314
AF - Africa 69
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.162
Nazione #
US - Stati Uniti d'America 2.987
SG - Singapore 938
RU - Federazione Russa 855
IE - Irlanda 604
CN - Cina 480
IT - Italia 439
DE - Germania 378
SE - Svezia 315
VN - Vietnam 306
HK - Hong Kong 263
BR - Brasile 243
FR - Francia 227
UA - Ucraina 198
FI - Finlandia 126
IN - India 103
GB - Regno Unito 86
KR - Corea 56
CA - Canada 42
ID - Indonesia 40
AR - Argentina 32
PL - Polonia 30
BD - Bangladesh 29
BJ - Benin 25
MX - Messico 23
AT - Austria 22
CZ - Repubblica Ceca 22
ZA - Sudafrica 20
BE - Belgio 16
NL - Olanda 16
TR - Turchia 16
JP - Giappone 15
IQ - Iraq 14
EC - Ecuador 12
CL - Cile 10
ES - Italia 10
IR - Iran 9
PH - Filippine 8
AU - Australia 7
CO - Colombia 6
JO - Giordania 6
KE - Kenya 6
PK - Pakistan 6
TH - Thailandia 6
UZ - Uzbekistan 6
AL - Albania 5
CH - Svizzera 5
EG - Egitto 5
VE - Venezuela 5
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
MA - Marocco 3
OM - Oman 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.162
Città #
Dublin 604
San Jose 432
Jacksonville 360
Hong Kong 258
Ashburn 215
Singapore 197
Dearborn 166
Chandler 152
Beijing 136
Council Bluffs 95
Ho Chi Minh City 92
Los Angeles 92
Wilmington 90
Moscow 87
Ann Arbor 81
Piemonte 76
Lauterbourg 72
Lawrence 71
Princeton 71
Hanoi 70
Milan 63
San Mateo 58
Seoul 53
Buffalo 47
Novara 46
Munich 42
Andover 41
New York 40
Turin 33
Santa Clara 32
São Paulo 30
Jakarta 29
Nuremberg 27
Frankfurt am Main 26
Warsaw 26
Cotonou 25
Houston 22
Columbus 21
Helsinki 21
Brno 20
Brooklyn 19
Dallas 19
Orem 19
Guangzhou 18
Nanjing 18
Denver 17
Hillsboro 17
Atlanta 16
Brussels 16
Chicago 16
Dong Ket 16
Boardman 15
Johannesburg 15
Chennai 14
Haiphong 14
Tianjin 14
Hefei 13
London 13
Woodbridge 13
Poplar 12
Redondo Beach 12
Stockholm 12
Da Nang 11
Falkenstein 11
Mexico City 11
Norwalk 11
Rome 11
Tokyo 11
Toronto 11
Düsseldorf 10
Montreal 10
Mumbai 10
Shanghai 10
Manchester 9
Philadelphia 9
Seattle 9
Boston 8
Bremen 8
Turku 8
City of London 7
Grafing 7
Phoenix 7
Strasbourg 7
Vercelli 7
Alessandria 6
Amman 6
Augusta 6
Berlin 6
Fairfield 6
Hangzhou 6
Jinan 6
Kunming 6
Nairobi 6
Amsterdam 5
Ankara 5
Baghdad 5
Biên Hòa 5
Bologna 5
Brasília 5
Can Tho 5
Totale 4.749
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 276
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 257
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 230
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 200
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 180
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 162
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 149
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 137
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 136
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 134
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 132
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 130
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 130
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 129
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 128
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 127
Diagnostic value of FibroTest with normal serum aminotransferases 123
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 122
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 120
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 117
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 116
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 115
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 115
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 115
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 115
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 114
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 114
ACE genotype, body weight changes and target organ damage in renal transplant recipients 113
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 110
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 109
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 109
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 108
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 107
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 106
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 106
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 106
Chlamydia trachomatis prevalence in North-West Italy 104
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 103
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 101
Acquired post partum hemophilia 101
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 101
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 100
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 98
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 98
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 95
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 95
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 93
Plasma Extracellular Vesicles from Preeclamptic Patients Trigger a Detrimental Crosstalk Between Glomerular Endothelial Cells and Podocytes Involving Endothelin-1 92
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study 92
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 92
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 92
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 92
Vascular endothelial growth factor. From basic research to clinical application 89
Use, misuse and abuse of diuretics 88
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 86
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 86
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 85
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 85
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 84
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 84
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 84
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 84
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 83
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 83
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 82
Clinical Features and Outcomes of Patients with Full Spectrum of COVID-19 Severity and Concomitant Herpesvirus Reactivation 81
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 81
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 80
Sexually transmitted diseases and pelvic inflammatory disease 80
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 79
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 79
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 76
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 75
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 73
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 73
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 72
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 72
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 72
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 71
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 71
Imatinib mesilate: New perspectives in the treatment of solid tumours 71
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 70
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 68
The Impact of the G6PD Gene Mutations in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Multicenter Observational Study 67
Imatinib mesylate: new perspectives in the treatment of solid tumours 66
Evaluation of plasma interferon alpha concentration as a marker of disease severity in human psoriasis 55
Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers 51
Mitochondrial Dysfunction: The Cellular Bridge from Emo-tional Stress to Disease Onset. A narrative review 43
The Role of Vitamin D in Autoimmune Diseases 42
Extracellular Vesicles as Mediators of Endothelial and Tubular Injury in Cardiac Surgery-Associated Acute Kidney Injury 27
What is your next step? A case of how a misleading diagnosis can mask avoidable serious adverse effects of quetiapine 23
Thinking outside the box: a case of unexplained ascites in an adult 15
Liver involvement in hospitalized patients with West Nile Virus infection 1
Totale 9.283
Categoria #
all - tutte 42.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022570 12 22 93 58 35 15 64 19 48 28 67 109
2022/20231.273 141 55 67 33 65 130 27 73 618 6 44 14
2023/2024490 35 54 35 15 87 8 93 17 14 11 42 79
2024/20251.406 25 7 45 20 26 70 160 86 249 135 218 365
2025/20263.966 153 151 250 541 394 238 638 696 284 309 221 91
Totale 9.283